822 results on '"Mir O."'
Search Results
202. Impact of sarcopenia (Sp) on early dose-limiting toxicity (DLT) and acute vascular toxicity in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving sunitinib (SUT).
203. Does visceral fat area (VFA) have predictive value for hypertension (HTN) and progression-free survival (PFS) in patients (pts) with stage IV NSCLC receiving bevacizumab (Beva)?
204. Pemetrexed (Pem), oxaliplatin (Ox), and bevacizumab (Beva) as first-line therapy in patients (pts) with stage IV lung adenocarcinoma.
205. Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult patients with cancer with advanced solid tumors.
206. Chimiothérapie des patients atteints de cancer de vessie et unfit
207. Proposal of a new population pharmacokinetics (PK) model of sorafenib and rationale for a three-daily schedule.
208. Metronomic oral cyclophosphamide (CPM) and prednisolone in elderly patients (pts) with inoperable or metastatic soft tissue sarcoma (STS).
209. 23 Pregnancy-associated breast cancer is as chemosensitive as classic breast cancer in the neoadjuvant setting
210. Cancer du sein associé à la grossesse
211. P97 Bevacizumab-induced hypertension in ≥70 years-old patients with metastatic solid tumors
212. Vinorelbine plus oxaliplatin in unfit patients (pts) with stage IV non-small cell lung cancer (NSCLC)
213. Prevention of high-dose methotrexate acute toxicity using a rescue protocol combining hyper-alkalinization followed by continuous infusion of leucovorin in osteosarcoma patients
214. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression
215. VARIABLE BRONCHODILATOR RESPONSE IN 6867 PULMONARY FUNCTION TESTS
216. Relationship between glutathione-S-transferase P1 Ile105Val polymorphism and docetaxel neurosensory toxicity
217. Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy
218. Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?
219. Oxaliplatin in inoperable or metastatic bladder cancer
220. Hyper-alkalinization instead of hyper-hydration for the prevention of high-dose methotrexate (HDMTX) induced nephrotoxicity in osteosarcoma patients
221. Concomitant administration of high-dose methotrexate (HDMTX) and ifosfamide in osteosarcoma patients: A clinico-pharmacological study
222. Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report
223. VARIABLE BRONCHODILATOR RESPONSE IN 6867 PULMONARY FUNCTION TESTS
224. Traitement de la maladie de Behçet à localisationoculaire par l'infliximab
225. Agammaglobulinémie de Bruton et carenceen vitamine B12
226. Diaphragme de l'intestin grèle et inhibiteurs sélectifsde la cyclo-oxygénase-2
227. Adénosine désaminase : quelle valeur dans le diagnostic de la tuberculose?
228. A high carbohydrate diet does not induce hyperglycaemia in a mitochondrial glycerol-3-phosphate dehydrogenase-deficient mouse
229. Uncommon bladder cancers.
230. Un glissement trop fébrile
231. LBA45 - A Randomized Multicentre Phase Ii Study of Pazopanib Plus Best Supportive Care (Bsc) Vs Bsc Alone in Metastatic Gastrointestinal Stromal Tumors (Gist) Resistant to Imatinib and Sunitinib
232. 1549P - Hypertension, Proteinuria and Overall Survival in Elderly Cancer Patients Treated with Bevacizumab
233. 1415O - Outcome of First-Line Treatment of Elderly Advanced Soft Tissue Sarcoma (Sts) Patients: a Pooled Analysis of Eleven Eortc Soft Tissue and Bone Sarcoma Group Trials
234. 1414O - Benefit of Maintenance Therapy with Trabectedin (T) Beyond the 6 First Cycles: Results of a Prospective Randomized Phase Ii Trial Comparing Interruption Vs. Continuation of T in Patients (Pts) with Advanced Soft Tissue Sarcoma (Asts): an Update
235. Intraoperative motive for incomplete resection in primary retroperitoneal sarcoma
236. Hépatite virale C associée à un lymphome splénique de type villeux : Un traitement unique
237. Erythroblastopénie induite par l'isoniazide : À propos d'un cas
238. Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib--hype or me-too?
239. Apport de l'imagerie dans l'évaluation des masses et métastases cardiaques.
240. Low skeletal muscle is associated with toxicity in patients included in phase I trials.
241. Return visits to the emergency department
242. Quels traitements anticancéreux pendant la grossesse ?
243. Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy.
244. Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.
245. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
246. Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.
247. Structuration nationale pour la prise en charge des cancers en cours de grossesse : réseau CALG (cancers associés à la grossesse).
248. Is anagrelide safe during pregnancy?
249. Accidental blood exposures among medical residents in Paris, France.
250. Taxanes for breast cancer during pregnancy: a systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.